A. Liberati - Researcher Profile | RDL Research Database

Publications

3 shown

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

A. Liberati , Doug Altman , Jennifer Tetzlaff +7 more

Systematic reviews and meta-analyses are essential to summarise evidence relating to efficacy and safety of healthcare interventions accurately and reliably. The clarity and tra...

2009 BMJ 16839 citations

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

David Moher , A. Liberati , Jennifer Tetzlaff +1 more

David Moher and colleagues introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses

2009 BMJ 81955 citations

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

Larissa Shamseer , David Moher , Mike Clarke +5 more

Protocols of systematic reviews and meta-analyses allow for planning and documentation of review methods, act as a guard against arbitrary decision making during review conduct,...

2015 BMJ 12371 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 111,165
Institution: Mario Negri Institute for Pharmacological Research

External Links

Google Scholar

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.